Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.

Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.

Item
http://www.wikidata.org/entity/Q35195457
5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological studyInflammatory mechanisms contributing to pancreatic cancer development.Indications for 5-aminosalicylate in inflammatory bowel disease: is the body of evidence complete?Small bowel adenocarcinoma in Crohn's disease: a case report and review of literature.Risk factors for ulcerative colitis-associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: results of a population-based study.5-aminosalicylic acid in combination with nimesulide inhibits proliferation of colon carcinoma cells in vitroCON: surveillance for ulcerative colitis-associated cancer: time to change the endoscopy and the microscopy.5-aminosalicylic acid is an attractive candidate agent for chemoprevention of colon cancer in patients with inflammatory bowel disease.Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre miceA case of small bowel adenocarcinoma in a patient with Crohn's disease detected by PET/CT and double-balloon enteroscopy.Current issues in inflammatory bowel disease neoplasia.Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular "pseudoinflammation" contributing to an aggressive phenotypeChemoprevention of colonic polyps with balsalazide: an exploratory, double-blind, placebo-controlled study.Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.Mesalazine (5-aminosalicylic acid) micropellets show similar efficacy and tolerability to mesalazine tablets in patients with ulcerative colitis--results from a randomized-controlled trial.5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.Mortality in inflammatory bowel disease in the Netherlands 1991-2002: results of a population-based study: the IBD South-Limburg cohort.
P2860

Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.

Item
http://www.wikidata.org/entity/Q35195457
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
@ast
Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
@en
type
label
Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
@ast
Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
@en
prefLabel
Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
@ast
Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
@en
P2093
P2860
P304
P31
P356
10.1111/J.1572-0241.2003.07599.X
P407
P433
P478
P577
P5875
P698
P921